Synthetic group A streptogramin antibiotics that overcome Vat resistance
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Natural products serve as chemical blueprints for most antibiotics in clinical use. The evolutionary process by which these molecules arise is inherently accompanied by the co-evolution of resistance mechanisms that shorten the clinical lifetime of any given class of antibiotics1. Virginiamycin acetyltransferase (Vat) enzymes are resistance proteins that provide protection against streptogramins2, potent antibiotics against Gram-positive bacteria that inhibit the bacterial ribosome3. Owing to the challenge of selectively modifying the chemically complex, 23-membered macrocyclic scaffold of group A streptogramins, analogues that overcome the resistance conferred by Vat enzymes have not been previously developed2. Here we report the design, synthesis, and antibacterial evaluation of group A streptogramin antibiotics with extensive structural variability. Using cryo-electron microscopy and forcefield-based refinement, we characterize the binding of eight analogues to the bacterial ribosome at high resolution, revealing binding interactions that extend into the peptidyl tRNA-binding site and towards synergistic binders that occupy the nascent peptide exit tunnel. One of these analogues has excellent activity against several streptogramin-resistant strains of Staphylococcus aureus, exhibits decreased rates of acetylation in vitro, and is effective at lowering bacterial load in a mouse model of infection. Our results demonstrate that the combination of rational design and modular chemical synthesis can revitalize classes of antibiotics that are limited by naturally arising resistance mechanisms. Modular synthesis and structural biology are used to design and characterize group A streptogramin antibiotics, one of which has activity against streptogramin-resistant strains and demonstrates efficacy in a mouse model of bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Automated multiconformer model building for X-ray crystallography and cryo-EM
Wankowicz, S. A., Ravikumar, A., Sharma, S., Riley, B., Raju, A., Hogan, D. W., Flowers, J., van den Bedem, H., Keedy, D. A., & Fraser, J. S. (2024) · eLife · doi:10.7554/elife.90606 · Cited by 28
Self-citation(2023) · doi:10.1101/2023.06.28.546963 · Cited by 8
Metadata
- Authors
- Li, Q., Pellegrino, J., Lee, D. J., Tran, A. A., Chaires, H. A., Wang, R., Park, J. E., Ji, K., Chow, D., Zhang, N., Brilot, A. F., Biel, J. T., van Zundert, G., Borrelli, K., Shinabarger, D., Wolfe, C., Murray, B., Jacobson, M. P., Mühle, E., Chesneau, O., Fraser, J. S., & Seiple, I. B.
- Venue
- Nature
- Published
- 2020-09-23
- Volume
- 586
- Issue
- 7827
- Pages
- 145-150
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3088036532
- Cited by
- 118
- References
- 2
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synthetic group A streptogramin antibiotics that overcome Vat resistance. https://app.cochat.ai/papers/10.1038/s41586-020-2761-3
- The paper
- Li, Q., Pellegrino, J., Lee, D. J., Tran, A. A., Chaires, H. A., Wang, R., Park, J. E., Ji, K., Chow, D., Zhang, N., Brilot, A. F., Biel, J. T., van Zundert, G., Borrelli, K., Shinabarger, D., Wolfe, C., Murray, B., Jacobson, M. P., Mühle, E., . . . Seiple, I. B. (2020). Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature. https://doi.org/10.1038/s41586-020-2761-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.